LentiGuide Puro-P2A-EGFP Citations (2)

Originally described in: IL-4 controls activated neutrophil FcgammaR2b expression and migration into inflamed joints.
Panda SK, Wigerblad G, Jiang L, Jimenez-Andrade Y, Iyer VS, Shen Y, Boddul SV, Guerreiro-Cacais AO, Raposo B, Kasza Z, Wermeling F Proc Natl Acad Sci U S A. 2020 Jan 24. pii: 1914186117. doi: 10.1073/pnas.1914186117. PubMed Journal

---

Articles Citing LentiGuide Puro-P2A-EGFP

Articles
A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML. Guo HZ, Feng RX, Zhang YJ, Yu YH, Lu W, Liu JJ, Yang SX, Zhao C, Zhang ZL, Yu SH, Jin H, Qian SX, Li JY, Zhu J, Shi J. Cell Rep Med. 2024 Jun 18;5(6):101592. doi: 10.1016/j.xcrm.2024.101592. Epub 2024 Jun 5. PubMed
A multiplex, prime editing framework for identifying drug resistance variants at scale. Abadie FMC, Suiter CC, Smith NT, Daza RM, Rominger MC, Parrish P, McDiarmid TA, Lalanne JB, Martin B, Calderon D, Ellison A, Berger AH, Shendure J, Starita LM. Cell Genom. 2026 Feb 20:101167. doi: 10.1016/j.xgen.2026.101167. PubMed

If you have published an article using this material, please email us at to have your article added to this page.